- $12.74m
- $7.49m
Annual balance sheet for Imunon, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 17.2 | 49.4 | 34.2 | 15.7 | 5.87 |
| Net Total Receivables | 0 | 0.109 | 0.129 | 0 | — |
| Prepaid Expenses | |||||
| Total Current Assets | 18.8 | 51.9 | 37.2 | 18.2 | 8.01 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.34 | 1.17 | 0.704 | 2.35 | 1.66 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 37.5 | 74 | 44 | 21.9 | 9.72 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.75 | 6.77 | 10 | 7.39 | 4.79 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 18.9 | 18.3 | 14.6 | 8.53 | 5.47 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 18.6 | 55.8 | 29.3 | 13.4 | 4.24 |
| Total Liabilities & Shareholders' Equity | 37.5 | 74 | 44 | 21.9 | 9.72 |
| Total Common Shares Outstanding |